radionuclides physical characteristics make attractive candidates radioimmunotherapy high linear energy transfer b short path lengths microm c limited ability cells repair damage dna article describes pharmacokinetic bioactivity toxicity chemical characteristics 213bi 212bi radiometal conjugated hum195 constructs conjugation hum195 resulted attachment NUMBER chelating ligand molecules antibody results radiolabeling efficiency construct 213bi n NUMBER NUMBER min specific activities NUMBER immunoreactivity chxadtpahum195 construct n NUMBER independent specific activity chxadtpahum195 construct rapidly internalized cell manner ranging NUMBER NUMBER h NUMBER NUMBER h constructs stable NUMBER d vitro presence human serum NUMBER degrees c injection mice uptake loss bismuth mouse tissues express cd33 kidney avidity free bismuth mice injected intraperitoneally doses NUMBER ranging NUMBER NUMBER showed toxicity NUMBER mice died NUMBER wk mouse showed significant reductions white blood cell counts mice injected intravenously doses NUMBER exhibited little toxicity NUMBER mtd mice leukemia cell killing vitro hum1 NUMBER showed specific killing cd33 hl60 cells approximately NUMBER killing observed bismuth atoms NUMBER fm radiolabeled antibody initially bound target cell surface conclusion antibodies potent cytotoxic agents known specific appear safe vivo physical biochemical characteristics 213bi isotope generation biochemistry chxadtpahum195 construct make possible use constructs safely feasibly humans therapeutic levels alpha particle emitting NUMBER NUMBER alpha particle emitting anti cd33 scn chx dtpa chx dtpa hum195 NUMBER 213bi labeled NUMBER bismuth labeled time dependent labeled 213bichx dtpa hum1 213bichx dtpa hum195 bismuth labeled dose activity dependent alpha emitting 213bi labeled mbq mg mbq kg mbq kg mbq kg mbq kg NUMBER NUMBER 205bi 206bi